摘要
目的:研究非编码长链RNA ANRIL(lncRNA-ANRIL)和对氧磷酶1(PON1)在冠心病患者血清表达水平,并探讨其与冠心病患者临床意义。方法:选择2018年2月到2021年2月在我院接受治疗的冠心病患者70例作为研究组,同时随机选取同期在我院进行体检的健康志愿者70例作为对照组。比较两组患者血清lncRNA-ANRIL相对表达水平和PON1含量。采用Pearson法分析冠心病患者血清lncRNA-ANRIL相对表达水平和PON1含量与收缩压(SBP)、舒张压(DBP)、总胆固醇(TC)、甘油三脂(TG)、高密度脂蛋白(HDL-C)以及低密度脂蛋白(LDL-C)间的相关性。采用多因素Logistic回归分析冠心病发生的影响因素。结果:(1)研究组患者SBP、DBP、TG、TC和LDL-C显著高于对照组,而HDL-C显著低于对照组(P<0.05);(2)研究组血清lncRNA ANRIL Exon1-2和Exon 17-18相对表达水平均低于对照组,研究组血清PON1含量低于对照组(P<0.05)(3)血清ANRIL Exon 1-2和Exon 17-18相对表达水平与SBP.DBP.TG.TC和LDL-C均呈负相关,与HDLC呈正相关(P<0.05);(4)血清PON1含量与SBP、DBP、TG.TC和LDL-C均呈负相关,与HDL-C、血清ANRIL Exon 1-2和Exon 17-18相对表达水平均呈正相关(P<0.05);(5)多因素Logistic回归分析显示:TC、SBPDBP、TG和LDL-C是冠心病发病的危险因素,HDL-C、血清ANRILExon1-2和Exon 17-18相对表达水平、以及血清PON1含量是冠心病发病的保护因素。结论:冠心病患者血清lncRNA-ANRIL相对表达水平和PON1含量均降低,两者与冠心病患者血压及血脂代谢指标显著相关,且两者均为冠心病发病的保护因素。
Objective:To study the expression levels of lncRNA-ANRIL and PON1 in the serum of patients with coronary heart disease,and to explore their clinical significance in patients with coronary heart disease.Methods:70 patients with coronary heart disease who were treated in our hospital from February 2018 to February 2021 were selected as the research group,and 70 healthy volunteers who underwent physical examinations in our hospital during the same period were randomly selected as the control group.The relative expression level of lncRNA-ANRIL and the content of PON1 in the serum of the two groups were compared.Pearson’s method was used to analyze the correlation between the relative expression level of serum lncRNA-ANRIL,PON1 content in patients with coronary heart disease and SBP,DBP,TC,TG,HDL-C and LDL-C.Multivariate Logistic regression was used to analyze the influencing factors of coronary heart disease.Results:(1) SBP,DBP,TG,TC and LDL-C in the study group were significantly higher than those in the control group,while HDL-C was significantly lower than that in the control group(P<0.05);(2) The relative expression levels of lncRNA ANRIL Exon 1-2 and Exon 17-18 in the study group were lower than those in the control group,and the serum PON1 content in the study group was lower than that in the control group(P<0.05);(3) The relative expression levels of ANRIL Exon 1-2 and Exon 17-18 in serum were negatively correlated with SBP,DBP,TG,TC and LDL-C,and positively correlated with HDL-C(P<0.05);(4) The serum PON1 content was negatively correlated with SBP,DBP,TG,TC and LDL-C,and positively correlated with HDL-C,ANRIL Exon 1-2 and Exon 17-18in serum(P<0.05).(5) Multivariate Logistic regression analysis showed that TC,SBP,DBP,TG and LDL-C were risk factors for CHD,while HDL-C,serum ANRIL Exon 1-2 and Exon 17-18 relative expression levels,and serum PON1 content were protective factors for CHD.Conclusion:Both the relative expression level of lncrna-AnRIL and the content of PON1 in serum were decreased in patients with
作者
王萌萌
金钊
张秀静
侯昌
许晓英
WANG Meng-meng;JIN Zhao;ZHANG Xiu-jing;HOU Chang;Xü Xiao-ying(Department ofCardiology,Beijing Changping Hospital of Integrated Chinese and Westermn Medicine,Beijing,102208,China;Department ofCardiology II,Bejjing Changping Hospital of Integrated Chinese and Western Medicine,Bejjing,102208,China;Department of Cardiology,Beijing University of Chinese Medicine Third Afiliated Hospital,Bejjing,100029,China;Department of Cardiology,Peking University People's Hospital,Beijing,10000,China;Geriatrics Departmen,Beijig Changping Hospital of Integrated Chinese and Western Medicine,Bejing,102208,China)
出处
《现代生物医学进展》
CAS
2022年第9期1790-1794,共5页
Progress in Modern Biomedicine
基金
首都卫生发展科研专项批准项目(首发2016-3-7111)。
